Annual report
4885.TEDINET S100YYBG
Period2025-06-01 → 2026-05-31
Filed2026-08-25
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 93
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.8bn | 2025-06-01 → 2026-05-31 | Standalone | Net sales |
| Revenue | ¥6.7bn | 2024-06-01 → 2025-05-31 | Standalone | Net sales |
| Revenue | ¥6.4bn | 2023-06-01 → 2024-05-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.3bn | 2022-06-01 → 2023-05-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.7bn | 2021-06-01 → 2022-05-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥743m | 2025-06-01 → 2026-05-31 | Standalone | Operating income |
| Operating income | ¥432m | 2024-06-01 → 2025-05-31 | Standalone | Operating income |
| Ordinary income | ¥707m | 2025-06-01 → 2026-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥430m | 2024-06-01 → 2025-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥428m | 2023-06-01 → 2024-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥351m | 2022-06-01 → 2023-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥423m | 2021-06-01 → 2022-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥328m | 2025-06-01 → 2026-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥350m | 2024-06-01 → 2025-05-31 | Standalone | Income before income taxes |
| Net income | ¥163m | 2025-06-01 → 2026-05-31 | Standalone | Profit loss |
| Net income | ¥241m | 2024-06-01 → 2025-05-31 | Standalone | Profit loss |
| Net income | ¥330m | 2023-06-01 → 2024-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥256m | 2022-06-01 → 2023-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥456m | 2021-06-01 → 2022-05-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥6.4bn | at 2026-05-31 | Standalone | Assets |
| Total assets | ¥5.3bn | at 2025-05-31 | Standalone | Assets |
| Total assets | ¥5.1bn | at 2024-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.9bn | at 2023-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.8bn | at 2022-05-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.8bn | at 2026-05-31 | Standalone | Liabilities |
| Total liabilities | ¥2.8bn | at 2025-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.6bn | at 2026-05-31 | Standalone | Net assets |
| Net assets / equity | ¥2.5bn | at 2025-05-31 | Standalone | Net assets |
| Net assets / equity | ¥2.3bn | at 2024-05-31v | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-05-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.7bn | at 2022-05-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2026-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2025-05-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.9bn | at 2026-05-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2025-05-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-05-31v | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥853m | at 2023-05-31v | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥865m | at 2022-05-31v | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥808m | 2025-06-01 → 2026-05-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥216m | 2024-06-01 → 2025-05-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥638m | 2023-06-01 → 2024-05-31v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥317m | 2022-06-01 → 2023-05-31v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥525m | 2021-06-01 → 2022-05-31v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥238m | 2025-06-01 → 2026-05-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥371m | 2024-06-01 → 2025-05-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥232m | 2023-06-01 → 2024-05-31v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥162m | 2022-06-01 → 2023-05-31v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥176m | 2021-06-01 → 2022-05-31v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥318m | 2025-06-01 → 2026-05-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥123m | 2024-06-01 → 2025-05-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥210m | 2023-06-01 → 2024-05-31v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥172m | 2022-06-01 → 2023-05-31v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥484m | 2021-06-01 → 2022-05-31v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥40.58 | 2025-06-01 → 2026-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.42 | 2024-06-01 → 2025-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥83.42 | 2023-06-01 → 2024-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.94 | 2022-06-01 → 2023-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.79 | 2021-06-01 → 2022-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.99 | 2025-06-01 → 2026-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥59.49 | 2024-06-01 → 2025-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥81.86 | 2023-06-01 → 2024-05-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥64.12 | 2022-06-01 → 2023-05-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥112.56 | 2021-06-01 → 2022-05-31v | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥26 | 2025-06-01 → 2026-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥25 | 2024-06-01 → 2025-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥22 | 2023-06-01 → 2024-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19 | 2022-06-01 → 2023-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19 | 2021-06-01 → 2022-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥640.13 | at 2026-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥612.4 | at 2025-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥571.26 | at 2024-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥487.25 | at 2023-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥450.37 | at 2022-05-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 40.6% | at 2026-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.6% | at 2025-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.9% | at 2024-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.7% | at 2023-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.0% | at 2022-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.5% | 2025-06-01 → 2026-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.2% | 2024-06-01 → 2025-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.8% | 2023-06-01 → 2024-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.3% | 2022-06-01 → 2023-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 30.3% | 2021-06-01 → 2022-05-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 4,095,500 | at 2026-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2025-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2024-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2023-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2022-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 199 | at 2026-05-31 | Standalone | Number of employees |
| Employees | 203 | at 2025-05-31 | Standalone | Number of employees |
| Employees | 205 | at 2024-05-31v | Standalone | Number of employees |
| Employees | 205 | at 2023-05-31v | Standalone | Number of employees |
| Employees | 197 | at 2022-05-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 53
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment assets | at 2026-05-31 | ¥2.7bn |
| Chemical Products Businessreportable segment | capex | 2025-06-01 → 2026-05-31 | ¥70m |
| Chemical Products Businessreportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥79m |
| Chemical Products Businessreportable segment | employees | at 2026-05-31 | 52 pure |
| Chemical Products Businessreportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥2.7bn |
| Chemical Products Businessreportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥2.7bn |
| Chemical Products Businessreportable segment | segment assets | at 2026-05-31 | ¥1.3bn |
| Chemical Products Businessreportable segment | segment profit | 2025-06-01 → 2026-05-31 | ¥91m |
| Healthy Food Businessreportable segment | capex | 2025-06-01 → 2026-05-31 | ¥10m |
| Healthy Food Businessreportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥12m |
| Healthy Food Businessreportable segment | employees | at 2026-05-31 | 12 pure |
| Healthy Food Businessreportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥1.2bn |
| Healthy Food Businessreportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥1.2bn |
| Healthy Food Businessreportable segment | segment assets | at 2026-05-31 | ¥230m |
| Healthy Food Businessreportable segment | segment profit | 2025-06-01 → 2026-05-31 | ¥18m |
| Pharmaceutical Businessreportable segment | capex | 2025-06-01 → 2026-05-31 | ¥166m |
| Pharmaceutical Businessreportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥99m |
| Pharmaceutical Businessreportable segment | employees | at 2026-05-31 | 52 pure |
| Pharmaceutical Businessreportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥4.0bn |
| Pharmaceutical Businessreportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥4.0bn |
| Pharmaceutical Businessreportable segment | segment assets | at 2026-05-31 | ¥2.2bn |
| Pharmaceutical Businessreportable segment | segment profit | 2025-06-01 → 2026-05-31 | ¥634m |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-06-01 → 2026-05-31 | ¥246m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-06-01 → 2026-05-31 | ¥191m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-06-01 → 2026-05-31 | ¥7.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-06-01 → 2026-05-31 | ¥7.8bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-05-31 | ¥3.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-06-01 → 2026-05-31 | ¥743m |
| Reconciling Itemsreconciling | segment assets | at 2025-05-31 | ¥1.7bn |
| Chemical Products Businessreportable segment | capex | 2024-06-01 → 2025-05-31 | ¥78m |
| Chemical Products Businessreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥61m |
| Chemical Products Businessreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥2.4bn |
| Chemical Products Businessreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥2.4bn |
| Chemical Products Businessreportable segment | segment assets | at 2025-05-31 | ¥1.1bn |
| Chemical Products Businessreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥57m |
| Healthy Food Businessreportable segment | capex | 2024-06-01 → 2025-05-31 | ¥33m |
| Healthy Food Businessreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥28m |
| Healthy Food Businessreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥1.0bn |
| Healthy Food Businessreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥1.0bn |
| Healthy Food Businessreportable segment | segment assets | at 2025-05-31 | ¥334m |
| Healthy Food Businessreportable segment | segment profit | 2024-06-01 → 2025-05-31 | −¥99m |
| Pharmaceutical Businessreportable segment | capex | 2024-06-01 → 2025-05-31 | ¥182m |
| Pharmaceutical Businessreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥74m |
| Pharmaceutical Businessreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥3.2bn |
| Pharmaceutical Businessreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥3.2bn |
| Pharmaceutical Businessreportable segment | segment assets | at 2025-05-31 | ¥2.1bn |
| Pharmaceutical Businessreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥474m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-06-01 → 2025-05-31 | ¥292m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-06-01 → 2025-05-31 | ¥162m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-06-01 → 2025-05-31 | ¥6.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-06-01 → 2025-05-31 | ¥6.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-05-31 | ¥3.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-06-01 → 2025-05-31 | ¥432m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,218
| Item | Context | Value | Unit |
|---|---|---|---|
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E36350-000PharmaceuticalBusinessReportableSegmentMember | 165684000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E36350-000HealthyFoodBusinessReportableSegmentMember | 10278000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E36350-000ChemicalProductsBusinessReportableSegmentMember | 70361000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 4095500 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 4095500 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 4095500 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 4095500 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 2 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 27 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 31 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 19 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 8 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 3423 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 3510 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 1745 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 2533 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 2599 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 557 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 64 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 33386 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 40884 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 7100 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.0427 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.0620 | |
| Percentage of shareholdings other corporations | CurrentYearInstant_OrdinaryShareMember | 0.0636 | |
| Percentage of shareholdings foreigners other than individuals | CurrentYearInstant_OrdinaryShareMember | 0.0136 | |
| Percentage of shareholdings foreign individuals | CurrentYearInstant_OrdinaryShareMember | 0.0016 | |
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.8166 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 410000 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.1019 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 356050 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.0885 | |
| Number of shares held | CurrentYearInstant_No3MajorShareholdersMember | 246998 | |
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.0614 | |
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 150000 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.0373 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 131000 | |
| Shareholding ratio | CurrentYearInstant_No5MajorShareholdersMember | 0.0325 | |
| Number of shares held | CurrentYearInstant_No6MajorShareholdersMember | 125600 | |
| Shareholding ratio | CurrentYearInstant_No6MajorShareholdersMember | 0.0312 | |
| Number of shares held | CurrentYearInstant_No7MajorShareholdersMember | 100000 | |
| Shareholding ratio | CurrentYearInstant_No7MajorShareholdersMember | 0.0248 | |
| Number of shares held | CurrentYearInstant_No8MajorShareholdersMember | 80800 | |
| Shareholding ratio | CurrentYearInstant_No8MajorShareholdersMember | 0.0201 | |
| Number of shares held | CurrentYearInstant_No9MajorShareholdersMember | 75000 | |
| Shareholding ratio | CurrentYearInstant_No9MajorShareholdersMember | 0.0186 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |